FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
medline:
7
6
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
ppublish
Résumé
A 43-year-old man with a growing mass in the right groin, concerned for liposarcoma, underwent MRI and 68 Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT before surgery. Fibroblast activation protein inhibitor PET/CT demonstrated increased uptake (SUV max , 3.2) predominantly in the solid portion, where MRI showed gadolinium enhancement. The patient subsequently underwent surgery and was diagnosed with hibernoma. The immunohistochemistry of the tumor revealed the fibroblast activation protein expression in the fibrovascular network and myofibroblastic cells of the tumor. This case suggests that the FAPI uptake can be affected by the vascular cells, and thus, a careful interpretation of the FAPI PET signal may be needed.
Identifiants
pubmed: 37146173
doi: 10.1097/RLU.0000000000004689
pii: 00003072-202307000-00037
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Gallium Radioisotopes
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e353-e355Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: J.C. is the recipient of grants from the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty), the Philippe Foundation Inc (New York), and the ARC Foundation (France) (International Mobility Award SAE20160604150). J.C. is a consultant for Blue Earth Diagnostics, Curium Pharma, GE Healthcare, Janssen Pharmaceuticals, Progenics Radiopharmaceuticals, Radiomedix, and Telix Pharmaceuticals, outside of the submitted work. The study was partially funded by the ERF- SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty). All other coauthors have no conflict of interest.
Références
Elqatni M, Ghafir D. Images in clinical medicine. Hibernoma of the neck. N Engl J Med . 2012;367:1636.
Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol . 2001;25:809–814.
Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci (Landmark Ed) . 2011;16:1233–1260.
Pothen L, D'Abadie P, Kozyreff A, et al. Hibernoma mimicking liposarcoma. Lancet . 2018;392:244.
Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer . 2016;16:582–598.
Koczorowska MM, Tholen S, Bucher F, et al. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. Mol Oncol . 2016;10:40–58.
Mona CE, Benz MR, Hikmat F, et al. Correlation of (68)Ga-FAPI-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med . 2022;63:1021–1026.
Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev . 2020;39:783–803.